Author： Duhovic Chris Child Fiona Wain E Mary
Publisher： Royal College Of Physicians
ISSN： 1470-2118
Source： Clinical Medicine, Vol.12, Iss.2, 2012-04, pp. : 160-164
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Guidelines for the management of cutaneous T-cell lymphoma have been released in the UK.
Inpharma, Vol. 1, Iss. 1420, 2004-01 ,pp. :
Access to resources
Recommend
Efalizumab: Progression of cutaneous T-cell lymphoma: case report
Reactions Weekly, Vol. 1, Iss. 1238, 2009-01 ,pp. :
Denileukin diftitox improves QOL in cutaneous T-cell lymphoma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 360, 2002-01 ,pp. :
Panobinostat is promising for the treatment of patients with cutaneous T-cell lymphoma
Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. :
Current and Emerging Treatment Strategies for Cutaneous T-cell Lymphoma
Drugs, Vol. 70, Iss. 3, 2010-02 ,pp. :